Fabentech

French tech company | Builders Republic

About

Biopharmaceutical company developing and manufacturing polyclonal antibody-fragment immunotherapies for medical emergencies — from avian flu and Ebola to biothreat antidotes for defence agencies, produced at its own bioproduction site in Lyon.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series C
Founded
2009
City
LYON
Region
Auvergne-Rhône-Alpes
Tracked rounds
2
Amount raised
14 M€

Operations

  • Series C · 2020
  • Series B · 2014

Investors